Bank of Montreal
BBIO icon

Bank of Montreal’s BridgeBio Pharma BBIO Stock Holding History

Bank of Montreal’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-200
Closed -$2 – 4075
2022
Q2 		$2 Sell
200
-700
-78% -$5.86K ﹤0.01% 3991
2022
Q1 		$9K Buy
+900
New +$9.24K ﹤0.01% 4007

Other funds holding BBIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Bank of Montreal's BBIO Position: Q2 2026 in Review

Bank of Montreal increased its BridgeBio Pharma (BBIO) stake by 3.7% in Q2 2026, buying an estimated $94.1K and bringing the position to 37,514 shares worth $2.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1597.

Bank of Montreal first reported a position in BBIO in Q2 2019 and has held it in 26 quarters since. The position peaked at $6.24M in Q3 2021. 328 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Bank of Montreal held 37,514 shares of BridgeBio Pharma worth $2.79M as of Q2 2026.
  • Bank of Montreal bought 1,343 BridgeBio Pharma shares in Q2 2026, an estimated $94.1K.
  • BridgeBio Pharma made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #1597 holding.
  • Bank of Montreal first reported a position in BridgeBio Pharma in Q2 2019 and has held it in 26 quarters since.
  • Bank of Montreal's BridgeBio Pharma position peaked at $6.24M in Q3 2021.
  • 328 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.